Advertisement
Screener

LogicBio Therapeutics, Inc. Patents: Applications Pending

LogicBio Therapeutics, Inc. Patent Applications Pending

28 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-10-24: Application 19478317; Invention MANUFACTURING AND USE OF RECOMBINANT SELF-COMPLEMENTARY AAV VECTORS; Applicant LogicBio Therapeutics, Inc.; Status Application Undergoing Preexam Processing.
  • 2024-04-16: Application 18701866; Invention GENE THERAPY FOR THE TREATMENT OF HT1; Applicant LogicBio Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2024-04-16: Application 18701852; Invention GENE THERAPY FOR THE TREATMENT OF WILSON'S DISEASE; Applicant LogicBio Therapeutics, Inc.; Status Non Final Action Mailed.
  • 2024-02-23: Application 18686355; Invention AAV PARTICLES COMPRISING A LIVER-TROPIC CAPSID PROTEIN AND ALPHA-GALACTOSIDASE AND THEIR USE TO TREAT FABRY DISEASE; Applicant LogicBio Therapeutics, Inc.; Status Non Final Action Mailed.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2025-10-2419478317MANUFACTURING AND USE OF RECOMBINANT SELF-COMPLEMENTARY AAV VECTORSLogicBio Therapeutics, Inc.Application Undergoing Preexam Processing
Matthias Charles Jerome HEBBEN
Jing LIAO
Carmen WU
Wilhad Hans REUTER
Thomas Matthew EDWARDS
United States
United States
United States
United States
United States
2024-04-1618701866GENE THERAPY FOR THE TREATMENT OF HT1LogicBio Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250177564A1
Qiang Xiong
Chih-Wei Ko
United States
United States
YU, DELPHINUS DOU YI
2024-04-1618701852GENE THERAPY FOR THE TREATMENT OF WILSON'S DISEASELogicBio Therapeutics, Inc.Non Final Action MailedUS20250144239A1
Shengwen Zhang
Jing Liao
Shaobin Wang
United States
United States
United States
LIPPOLIS, ALEXANDRA ROSE
2024-02-2318686355AAV PARTICLES COMPRISING A LIVER-TROPIC CAPSID PROTEIN AND ALPHA-GALACTOSIDASE AND THEIR USE TO TREAT FABRY DISEASELogicBio Therapeutics, Inc.
CANbridge Pharmaceuticals, Inc.
Non Final Action MailedUS20240424141A1
Yunxiang Zhu
Peter Pechan
Anannya Banga
Susana Gordo Villoslada
United States
United States
United States
United States
CHONG, KIMBERLY
2024-02-2318686145MODIFIED AAV CAPSID POLYPEPTIDES AND VECTORSLogicbio Therapeutics, Inc.
The Sydney Children's Hospitals Network (Randwick and Westmead) (Incorporating the Royal Alexandra H
Children's Medical Research Institute
Non Final Action MailedUS20240425549A1
Marti Cabanes Creus
Leszek Lisowski
Ian Alexander
Matthias Charles Jerome Hebben
Australia
Australia
Australia
United States
CORNELIUS, CLAIRE ADRIENNE
2023-10-2718288658VIRAL VECTOR COMPOSITIONS AND METHODS OF USE THEREOFLogicBio Therapeutics, Inc.Non Final Action MailedUS20250188488A1
Qiang Xiong
B. Nelson Chau
United States
United States
ABUZEINEH, HANAN ISAM
2023-10-0618482700MANUFACTURING AND USE OF RECOMBINANT AAV VECTORSLogicBio Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20240035047A1
Matthias Charles Jerome HEBBEN
Jing LIAO
Carmen WU
Wilhad Hans REUTER
Thomas Matthew EDWARDS
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2023-05-23PCTUS2023023285GENE THERAPY COMPOSITIONS AND METHODS OF USE THEREOFLOGICBIO THERAPEUTICS, INC.
ASTRAZENECA AB
RO PROCESSING COMPLETED-PLACED IN STORAGE
CHIH-CHIEH WANG
SHAOBIN WANG
DONALD JAMES FOSTER
ANNETTE BAK
LIPING ZHOU
BEI CHENG
United States
United States
United States
Sweden
Sweden
Sweden
2023-04-28PCTUS2023020452MANUFACTURING AND USE OF RECOMBINANT SELF-COMPLEMENTARY AAV VECTORSLOGICBIO THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
MATTHIAS CHARLES JEROME HEBBEN
JING LIAO
CARMEN WU
WILHAD HANS REUTER
THOMAS MATTHEW EDWARDS
United States
United States
United States
United States
United States
MATOS NEGRON, TAINA DEL MAR
2022-10-18PCTUS2022047007GENE THERAPY FOR THE TREATMENT OF WILSON'S DISEASELOGICBIO THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
SHENGWEN ZHANG
JING LIAO
SHAOBIN WANG
United States
United States
United States
THOMAS, SHANE M
2022-10-18PCTUS2022047003GENE THERAPY FOR THE TREATMENT OF HT1LOGICBIO THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
QIANG XIONG
CHIH-WEI KO
United States
United States
THOMAS, SHANE M
2022-08-2217801510ADENO-ASSOCIATED VIRUS CAPSID POLYPEPTIDES AND VECTORSLogicBio Therapeutics, Inc.
The Sydney Children's Hospital Network (Randwick and Westmead) (Incorporating the Royal Alexandra Ho
Children's Medical Research Institute
Publications -- Issue Fee Payment VerifiedUS20230093183A1
Leszek Lisowski
Marti Cabanes Creus
Ian Alexander
Matthias Charles Jerome Hebben
Australia
Australia
Australia
Australia
MONDESI, ROBERT B
2022-05-2363345003GENE THERAPY COMPOSITIONS AND METHODS OF USE THEREOFLogicBio Therapeutics, Inc.Provisional Application Expired
Chih-Chieh Wang
Shaobin Wang
Donald James Foster
United States
United States
United States
2022-05-0963339783GENE THERAPY FOR THE TREATMENT OF HT1LogicBio Therapeutics, Inc.Provisional Application Expired
Qiang Xiong
Chih-Wei Ko
United States
United States
2022-04-29PCTUS2022026988VIRAL VECTOR COMPOSITIONS AND METHODS OF USE THEREOFLOGICBIO THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
B. NELSON CHAU
QIANG XIONG
United States
United States
THOMAS, SHANE M
2022-02-25PCTUS2022017901MANUFACTURING AND USE OF RECOMBINANT AAV VECTORSLOGICBIO THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
MATTHIAS CHARLES JEROME HEBBEN
JING LIAO
THOMAS MATTHEW EDWARDS
WILHAD HANS REUTER
CARMEN WU
United States
United States
United States
United States
United States
KIM, HARRY CHONG HYUN
2021-10-1863257036MANUFACTURING AND USE OF RECOMBINANT AAV VECTORSLogicBio Therapeutics, Inc.Provisional Application Expired
Matthias Charles Jerome Hebben
Jing Liao
Carmen Wu
Wilhad Hans Reuter
Thomas Matthew Edwards
United States
United States
United States
United States
United States
2021-10-1863257031GENE THERAPY FOR THE TREATMENT OF WILSON'S DISEASELogicBio Therapeutics, Inc.Provisional Application Expired
Shengwen Zhang
Jing Liao
Shaobin Wang
United States
United States
United States
2021-10-1863257028GENE THERAPY FOR THE TREATMENT OF HT1LogicBio Therapeutics, Inc.Provisional Application Expired
Qiang Xiong
Chih-Wei Ko
United States
United States
2021-10-1417603935MONITORING GENE THERAPYLogicBio Therapeutics, Inc.Non Final Action MailedUS20220308070A1
B. Nelson Chau
Jing Liao
Susana Gordo
United States
United States
United States
GRABER, JAMES J
2021-08-2563237125AAV PARTICLES COMPRISING A LIVER-TROPIC CAPSID PROTEIN AND ACID ALPHA-GLUCOSIDASE (GAA) AND THEIR USE TO TREAT POMPE DISEASELogicBio Therapeutics, Inc.
CANbridge Pharmaceuticals, Inc.
Provisional Application Expired
Yunxiang Zhu
Peter Pechan
Anannya Banga
United States
United States
United States
2021-08-2563237122AAV PARTICLES COMPRISING A LIVER-TROPIC CAPSID PROTEIN AND ALPHA-GALACTOSIDASE AND THEIR USE TO TREAT FABRY DISEASELogicBio Therapeutics, Inc
CANbridge Pharmaceuticals, Inc.
Provisional Application Expired
Yunxiang Zhu
Peter Pechan
Anannya Banga
Susana Gordo Villoslada
United States
United States
United States
United States
2021-08-1863234610MANUFACTURING AND USE OF RECOMBINANT AAV VECTORSLogicBio Therapeutics, Inc.Provisional Application Expired
Matthias Charles Jerome Hebben
Jing Liao
Carmen Wu
Wilhad Hans Reuter
Thomas Matthew Edwards
France
United States
United States
United States
United States
2021-04-3063182738VIRAL VECTOR COMPOSITIONS AND METHODS OF USE THEREOFLogicBio Therapeutics, Inc.Provisional Application Expired
Qiang Xiong
B. Nelson Chau
United States
United States
2021-02-2663154474MANUFACTURING AND USE OF RECOMBINANT AAV VECTORSLogicBio Therapeutics, Inc.Provisional Application Expired
Matthias Charles Jerome Hebben
Jing Liao
Carmen Wu
Wilhad Hans Reuter
Thomas Matthew Edwards
France
United States
United States
United States
United States
2020-04-14PCTUS2020028102MONITORING GENE THERAPYLOGICBIO THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
B. NELSON CHAU
SUSANA GORDO
JING LIAO
United States
United States
United States
THOMAS, SHANE M
2019-04-1562833875MONITORING GENE THERAPYLogicBio Therapeutics, Inc.Provisional Application Expired
B. Nelson Chau
Jing Liao
Susana Gordo
United States
United States
United States
2018-08-1062717771NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMALogicBio Therapeutics, Inc.Provisional Application Expired
B. Nelson Chau
Kyle P. Chiang
Jing Liao
Charles P. Venditti
Randy J. Chandler
United States
United States
United States
United States
United States